Delivery Order SPE2DB20D2104-SPE2DB25FMAMT

Award Date 10/15/24
Potential Completion Date 10/16/24
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,543.40 delivery order contract is for the supply of Dupixent 300 mg/2 ml pens, a specialty medication. The contract has an ultimate completion date of January 8, 2025 and is a firm fixed price arrangement. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,411.62 firm-fixed-price delivery order is for Dupixent 300 mg/2 ml pens, with an ultimate completion date of December 12, 2023. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,111.47 firm fixed-price delivery order is for the supply of Dupixent 300 mg/2 ml pen, with an ultimate completion date of April 4, 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award, valued at $8,227.65, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Dupixent 300 mg/2 ml pen, a specialty medication. The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Dupixent 300 mg/2 ml pen, a specialty medication, with a ceiling value of $10,288.57 and a completion date of January 31, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,968.90 firm fixed-price delivery order is for the provision of Dupixent 300 mg/2 ml pens, a specialty pharmaceutical product, with a period of performance through December 31, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,635.58 firm fixed price delivery order is for the supply of Dupixent 300 mg/2 ml pens, a specialty medication. The contract has an ultimate completion date of February 20, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,672.46 firm fixed-price delivery order is for the supply of Dupixent 300 mg/2 ml pen, a pharmaceutical product, with a completion date of April 11, 2025. The contract is not set aside and represents an individual award under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 held by...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,696.91 firm fixed-price delivery order is for the supply of Dupixent 300 mg/2 ml pens, with an ultimate completion date of April 30, 2025. The award is not associated with a set-aside program and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00, which provides a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,233.70 firm fixed-price delivery order contract provides Dupixent 300 mg/2 ml pen, a specialty medication, to support military healthcare programs. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMAMT
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,652.35 firm fixed-price delivery order is for the supply of Dupixent 300 mg/2 ml pen, a specialty medication, with a completion date of October 16, 2024.

The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The IDC encompasses critical medical commodities across multiple therapeutic areas. This contract award was not designated with a set-aside requirement, indicating open competition.

Generated 2/27/25, 1:13 PM